GYNOBLEN

This brand name is authorized in Ecuador.

Active ingredients

The drug GYNOBLEN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII R3459K699K - SECNIDAZOLE
 

Secnidazole is a nitroimidazole antimicrobial drug that displays selectivity against many anaerobic Gram-positive and Gram-negative bacteria and protozoa.
 
Read more about Secnidazole
2
UNII 8VZV102JFY - FLUCONAZOLE
 

Fluconazole is a triazole antifungal agent. Its primary mode of action is the inhibition of fungal cytochrome P-450-mediated 14 alpha-lanosterol demethylation, an essential step in fungal ergosterol biosynthesis.
 
Read more about Fluconazole

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J02AC Triazole and tetrazole derivatives J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use
Discover more medicines within J02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 899-MEE-0415, 905-MEE-0415

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈